Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms

Area of Science:

• Biochemistry
• Pharmacology
• Enzymology

Background:

• Cyclooxygenase (Cox) enzymes, Cox-1 and Cox-2, are crucial in prostaglandin synthesis.
• Non-steroidal anti-inflammatory drugs (NSAIDs) target these enzymes, but often lack isoform selectivity.
• Selective Cox-2 inhibition is a strategy to mitigate NSAID-associated side effects.

Purpose of the Study:

• To characterize the kinetic mechanisms of interactions between purified human cyclooxygenase-1 (hCox-1) and cyclooxygenase-2 (hCox-2) and selective/non-selective NSAIDs.
• To elucidate the basis for the high selectivity of the Cox-2 inhibitor NS-398.

Main Methods:

• Kinetic analysis of purified recombinant hCox-1 and hCox-2 inhibition.
• Characterization of enzyme-inhibitor interactions using parameters like Ki and kon.
• Evaluation of time-dependent and time-independent inhibition mechanisms.

Main Results:

• NS-398, flurbiprofen, meclofenamic acid, and indomethacin are time-dependent, irreversible inhibitors of hCox-2.
• NS-398 exhibits time-independent, reversible inhibition of hCox-1.
• Flufenamic acid is a non-selective, time-independent inhibitor of both isoforms.

Conclusions:

• The differential time-dependency of inhibition between hCox-1 and hCox-2 underlies NS-398's high Cox-2 selectivity.
• Understanding these kinetic mechanisms is vital for developing safer and more effective anti-inflammatory drugs.